Skip to main content

1 Result(s)

within Yuanlong Xu Remove this filter

and

  1. Article

    Open Access

    Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials

    Lopinavir/ritonavir (LPV/r) is the first ritonavir-boosted protease-inhibitor used in second-line anti-retroviral treatment (ART) in resource-limited regions. To evaluate the efficacy and safety outcomes of LP...

    **aojie Huang, Yuanlong Xu, Qiuying Yang, Jieqing Chen, Tong Zhang… in Scientific Reports (2015)

    Download PDF (1540 KB) View Article